ePrivacy and GPDR Cookie Consent by TermsFeed Generator

TAKHZYRO

300MG INJ SOL 2X2ML+2STŘ+4J

SÚKL code 0238853
Name of the product TAKHZYRO
_MA_MEDICATION_DETAIL_INFO_MED_NAME i TAKHZYRO
Supplement 300MG INJ SOL 2X2ML+2STŘ+4J
Strenght 300MG
Pharmaceutical form Solution for injection
Package 2X2ML+2STŘ+4J
Route Subcutaneous use
Wrap type Vial
Legal status na lékařský předpis
Active substance LANADELUMAB (LANADELUMABUM)
ATC group B06AC05
ATC group name LANADELUMAB

Marketing authorisation information

Registration Number EU/1/18/1340/002
Type of MA Orphan medicinal products
MA status R - active MA/authorised medicinal product
MA Holder Takeda Pharmaceuticals International AG Ireland Branch, Dublin
MA Holder country IRSKO

Back to list